open access

Vol 12, No 1 (2006)
Original papers
Published online: 2006-03-27
Get Citation

Feasibility of revascularisation in patients with ischemic diabetic foot

Łukasz Dzieciuchowicz, Grzegorz Oszkinis, Zbigniew Krasiński, Katarzyna Motowidło, Katarzyna Pawlaczyk, Wacław Majewski
Acta Angiologica 2006;12(1):23-30.

open access

Vol 12, No 1 (2006)
Original papers
Published online: 2006-03-27

Abstract

Background. Ischemia of the lower extremity is the strongest risk factor of limb loss in patients with diabetic foot. The main purpose of this study was the evaluation of the feasibility and the early results of revascularisation in that group of patients.
Material and methods. A group of 120 patients with ischaemic diabetic foot (IDF) was analysed. The inclusion criteria were an ulcerated or necrotic foot, an absence of pulse on at least both foot arteries and diagnosed diabetes. Patients with deep infection in the foot requiring urgent surgical intervention were excluded. All patients underwent lower extremity arteriography. The decision about further treatment was based on the results of arteriography.
Results. In arteriography, diffuse atherosclerotic lesions in the femoro-popliteo-tibial segment dominated (71.6%). Aorto-iliac occlusive disease (16.6%) and isolated changes in the tibial arteries (11.6%) were less frequently observed. Femoro-popliteal bypass grafting was feasible in half of the patients, 18% of patients required distal grafts and 16% had the operations in the aorto-iliac segment. In 11% of the cases, because of lack of possibilities of revascularisation, patients were disqualified from surgery. The early limb salvage rate was 93.91 and 64% for the aorto-iliac, the femoro-popliteal and femoro-distal revascularisation, respectively. Almost all of the non-operated patients lost the lower limb.
Conclusion. The surgical revascularisation, mainly femoro-popliteal and femoro-distal grafts are feasible and effective in the treatment of IDF.

Abstract

Background. Ischemia of the lower extremity is the strongest risk factor of limb loss in patients with diabetic foot. The main purpose of this study was the evaluation of the feasibility and the early results of revascularisation in that group of patients.
Material and methods. A group of 120 patients with ischaemic diabetic foot (IDF) was analysed. The inclusion criteria were an ulcerated or necrotic foot, an absence of pulse on at least both foot arteries and diagnosed diabetes. Patients with deep infection in the foot requiring urgent surgical intervention were excluded. All patients underwent lower extremity arteriography. The decision about further treatment was based on the results of arteriography.
Results. In arteriography, diffuse atherosclerotic lesions in the femoro-popliteo-tibial segment dominated (71.6%). Aorto-iliac occlusive disease (16.6%) and isolated changes in the tibial arteries (11.6%) were less frequently observed. Femoro-popliteal bypass grafting was feasible in half of the patients, 18% of patients required distal grafts and 16% had the operations in the aorto-iliac segment. In 11% of the cases, because of lack of possibilities of revascularisation, patients were disqualified from surgery. The early limb salvage rate was 93.91 and 64% for the aorto-iliac, the femoro-popliteal and femoro-distal revascularisation, respectively. Almost all of the non-operated patients lost the lower limb.
Conclusion. The surgical revascularisation, mainly femoro-popliteal and femoro-distal grafts are feasible and effective in the treatment of IDF.
Citation Formats

Keywords

ischemic diabetic foot; revascularisation

About this article
Title

Feasibility of revascularisation in patients with ischemic diabetic foot

Journal

Acta Angiologica

Issue

Vol 12, No 1 (2006)

Pages

23-30

Published online

2006-03-27

Bibliographic record

Acta Angiologica 2006;12(1):23-30.

Keywords

ischemic diabetic foot
revascularisation

Authors

Łukasz Dzieciuchowicz
Grzegorz Oszkinis
Zbigniew Krasiński
Katarzyna Motowidło
Katarzyna Pawlaczyk
Wacław Majewski

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl